November 01, 2018
Nordic Nanovector: Promising results from preclinical studies with a novel CD37-targeted alpha therapy for B-cell tumours to be presented at ASH
Media
November 01, 2018
Nordic Nanovector highlights promising clinical results from Phase 1/2 trial of Betalutin® in relapsed/refractory indolent non-Hodgkin’s lymphoma
November 01, 2018
Oncopeptides to present updated data from the two ongoing trials ANCHOR and HORIZON in patients with RRMM at ASH in December 2018
November 01, 2018
BONESUPPORT HOLDING AB (publ) – Q3 2018 Interim Report – invitation to conference call and webcast
November 01, 2018
Targovax ASA: Third quarter 2018 results
October 31, 2018
Strongbridge Biopharma plc Reports Third Quarter 2018 Financial Results and Provides Corporate Update
October 31, 2018
Strongbridge Biopharma plc Enters into Agreement for Novo Nordisk to Acquire the U.S. and Canadian Rights to MACRILEN™ (macimorelin)
October 26, 2018
Targovax ASA: Announcement of Third Quarter 2018 Financial Results
October 26, 2018
Interim Report July – September 2018
October 26, 2018
GenSight Biologics enrolls first subject in first-in-man PIONEER Phase I/II clinical trial of GS030 combining gene therapy and Optogenetics for the treatment of Retinitis Pigmentosa